Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2005-02-01
2005-02-01
Chan, Christina (Department: 1644)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C530S351000, C536S023500
Reexamination Certificate
active
06849260
ABSTRACT:
Disclosed are novel methods and compositions for treating IgE-related diseases using NNT-1 inhibitors. In one embodiment, the present invention relates to a method of treating IgE-related diseases using a selective binding agent to NNT-1. In another embodiment, the present invention relates to a method of treating IgE-related diseases using an NNT-1 expression modulator. Methods of modulating IgE levels, and of diagnosing, preventing and/or treating certain types of allergic diseases using NNT-1 inhibitors are also disclosed.
REFERENCES:
patent: 5741772 (1998-04-01), Chang
patent: 5814649 (1998-09-01), Amano et al.
patent: 6034066 (2000-03-01), Johnson et al.
patent: 6054294 (2000-04-01), Chang
patent: 6143874 (2000-11-01), Chang
patent: WO 9833922 (1998-08-01), None
patent: WO 9900415 (1999-01-01), None
patent: WO 0074716 (2000-12-01), None
Abaza et al, J of Protein Chemistry 11(5): 433-444, 1992.*
Kuby et al, in Immunology, second edition, pp. 85-96, 1994.*
Attwood et al, The babel of bioinformatics, Science 290 (5491): 471-473, Oct. 2000.*
Skolnick et al, From genes to protein structure and function: novel applications of computational approaches in the genomic era, Trends in Biotech. 18(1): 34-39, Jan. 2000.*
Mikayama et al, Molecular cloning and functional expression of a cDNA encoding gycosylation-inhibting factor, Proc. Natl. Acad. Sci, USA vol. 90: 10056-10060, Nov. 1993.*
Arm et al.,Advances in Immunology“The pathiobiology of Brochial Asthma.” 51:323-382 (1992).
Chang,Nature Biotechnology“The pharmacological basis of anti-IgE therapy.” 18:157-162 (2000).
Rosenwasser, Lanny J.,Journal of Allergy and Clinical Immunology“New immunopharmacologic approaches to asthma: Role of cytokine antagonism.” 105:2 Part 2 S586-S591 (2000).
Senaldi et al.,Proc. Nat'l Acad. Sci.“Novel neurotrophin-1/B cell-stimulating fac tor-3: A cytokine of the IL-6 family.” 96:11458-11463 (1999).
Shi et al., Biochemical and Biophysical Res. Comm. “Computational EST Database Analysis Identifies a Novel Member of the Neuropoietic Cytokine Family.” 262:132-138 (1999).
Senaldi et al., “Regulatory Effects of Novel Neurotrophin-1/B Cell-Stimulating Factor-3 (Cardiotrophin-Like Cytokine) on B Cell Function” Journal of Immunology (2002) p. 5690-5698.
Amgen Inc.
Chan Christina
Huynh Phuong
Nicastro Karen L.
LandOfFree
Methods and compositions for treating IgE-related disease... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for treating IgE-related disease..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for treating IgE-related disease... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3472305